Spot Trading’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Spot Trading's BMY Position: Q3 2017 in Review
Spot Trading reduced its Bristol-Myers Squibb (BMY) stake by 80% in Q3 2017, selling an estimated $8.44M and leaving 36,605 shares worth $2.33M. The position accounts for 0.04% of the portfolio, ranked #641.
Spot Trading first reported a position in BMY in Q2 2013 and has held it in 15 quarters since. The position peaked at $10.1M in Q2 2017. 1,641 funds tracked by Wall St. Rank hold BMY as of Q3 2017.
- Spot Trading held 36,605 shares of Bristol-Myers Squibb worth $2.33M as of Q3 2017.
- Spot Trading sold 144,522 Bristol-Myers Squibb shares in Q3 2017, an estimated $8.44M.
- Bristol-Myers Squibb made up 0.04% of Spot Trading's portfolio in Q3 2017, its #641 holding.
- Spot Trading first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 15 quarters since.
- Spot Trading's Bristol-Myers Squibb position peaked at $10.1M in Q2 2017.
- 1,641 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2017.
Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.